Interleukin-2 in the treatment of hematologic malignancies

被引：0
|
作者：
Fefer, A
机构：
[1] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
CANCER JOURNAL | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S31 / S32
页数：2
相关论文
共 50 条
  • [31] Bendamustine in the treatment of hematologic malignancies
    Diehl, V
    Cheson, BD
    SEMINARS IN ONCOLOGY, 2002, 29 (04) : 1 - 3
  • [32] CLADRIBINE FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES
    BALTZ, JK
    MONTELLO, MJ
    CLINICAL PHARMACY, 1993, 12 (11): : 805 - 813
  • [33] HEMATOLOGIC EFFECTS OF LOW-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 WITH CONCOMITANT ALPHA-INTERFERON IN PATIENTS WITH METASTATIC SOLID MALIGNANCIES
    DAVE, HPG
    WHITE, C
    SCHULOF, R
    AVIS, FP
    CLINICAL RESEARCH, 1991, 39 (02): : A430 - A430
  • [34] Effects of low-dose recombinant interleukin-2 in human malignancies
    Lissoni, P
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 : S115 - S120
  • [35] EXPRESSION OF INTERLEUKIN-2 RECEPTOR BETA-SUBUNIT IN HEMATOPOIETIC MALIGNANCIES
    ROSOLEN, A
    NAKANISHI, M
    POPLACK, DG
    COLE, D
    QUINONES, R
    REAMAN, G
    TREPEL, JB
    COTELINGAM, JD
    SAUSVILLE, EA
    MARTI, GE
    JAFFE, ES
    NECKERS, LM
    COLAMONICI, OR
    BLOOD, 1989, 73 (07) : 1968 - 1972
  • [36] INTERLEUKIN-2 - PROSPECTS FOR LYMPHOCYTE-MEDIATED DESTRUCTION OF PEDIATRIC MALIGNANCIES
    SONDEL, PM
    JOURNAL OF PEDIATRICS, 1991, 118 (03): : S14 - S16
  • [37] INTERLEUKIN-2 AND T-CELL MALIGNANCIES - AN AUTOCRINE LOOP WITH A TWIST
    RUSSELL, SJ
    LEUKEMIA, 1989, 3 (10) : 755 - 757
  • [38] Immunotherapy of hematologic malignancies with autologous bone marrow transplant (ABMT) using in vitro interleukin-2 (IL-2)-treated bone marrow (BM).
    Margolin, K
    vanBesien, K
    Wright, C
    Woo, D
    Champlin, R
    Thomas, M
    Davis, M
    Grimm, E
    Forman, S
    BLOOD, 1995, 86 (10) : 1541 - 1541
  • [39] REGULATION OF INTERLEUKIN-2 RECEPTOR EXPRESSION BY INTERLEUKIN-2
    RESKEKUNZ, AB
    VONSTELDERN, D
    RUDE, E
    DIAMANTSTEIN, T
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1986, 23 (06) : 693 - 701
  • [40] High dose continuous infusion VP-16, ifosfamide, solumedrol and interleukin-2 (visit) in relapsed lymphoma and refractory hematologic malignancies.
    Goodman, M
    Spector, N
    Fernandez, HF
    Cassileth, PA
    Hurley, J
    BLOOD, 1995, 86 (10) : 3240 - 3240
12345